European Archives - Page 971 of 981 - European Medical Journal

EMJ Gastroenterology 2.1 2013

Welcome to the second edition of European Medical Journal – Gastroenterology which features a new and improved design and even more high-quality content.

Treatment of Hepatic Encephalopathy – Targeting the Gut-Liver-Brain Axis

Summary of Presentations from the Norgine Sponsored Satellite Symposium, UEG Week, Berlin, Germany, 12th–16th October 2013

State-of-the-Art Treatment of Irritable Bowel Syndrome – Recent Advances and Emerging Therapeutic Alternatives

Irritable bowel syndrome (IBS) is a highly prevalent functional disorder characterised by chronic and recurrent abdominal pain and altered bowel habit.

Understanding the Pathophysiology of IBS

While irritable bowel syndrome (IBS) is still considered a ‘disorder of gut function’ and is diagnosed on the basis of symptoms, evidence is growing to…

Practical Evaluation and Handling of Patients with Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a functional bowel disorder by unknown aetiology. Several reviews are written about pharmacological and psychological…

Endoscopic Optical Enhancement Technologies in IBD

Optical enhancement technologies are emerging as promising tools to improve diagnosis and clinical management of patients with IBD.

Adhesion Molecules as a Therapeutic Target in IBD

Recruitment of circulating leukocytes to areas of inflammation is a key process in the pathophysiology of inflammatory bowel diseases, including…

Effects of Antibiotic Use on the Microbiota of the Gut and Associated Alterations of Immunity and Metabolism

The excessively widespread use of antibiotics has created many threats. A well-known problem is the increasing bacterial resistance to antibiotics…

Managing Ulcerative Colitis: The Guidelines and Beyond

Management guidelines offer clinicians clear, evidence-based and often succinct treatment advice. For ulcerative colitis these guidelines describe the…

Non-Surgical Therapy for Unresectable Hilar Cholangiocarcinoma

Hilar cholangiocarcinoma (HCCA) is characterised by late clinical symptoms. As a consequence, most patients will not undergo surgery, and palliation is…